Your browser doesn't support javascript.
loading
Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board.
Loeb, Stacy; Cheng, Heather H; Paller, Channing J; Weg, Emily; Johnson, Jennifer; Gross, Laura; Keith, Scott W; Russo, Jessica; Hathaway, Feighanne; Rivera, Adrian; Giri, Veda N.
Affiliation
  • Loeb S; Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA. stacyloeb@gmail.com.
  • Cheng HH; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Paller CJ; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MA, USA.
  • Weg E; Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
  • Johnson J; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Gross L; Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Keith SW; Division of Biostatistics and Bioinformatics, Sidney Kimmel Medical Colllege, Thomas Jefferson University, Philadelphia, PA, USA.
  • Russo J; MD Anderson Cancer Center at Cooper University Health Care, Camden, NJ, USA.
  • Hathaway F; Hematology/Oncology, Biological Sciences Division, University of Chicago, Chicago, IL, USA.
  • Rivera A; Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY, USA.
  • Giri VN; Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Article in En | MEDLINE | ID: mdl-38172199
ABSTRACT

BACKGROUND:

Germline testing is important in prostate cancer and evaluation can be complex.

METHODS:

We instituted a monthly multi-disciplinary virtual genetics tumor board (7/2021-3/2022). Participants and panelists were surveyed on usefulness and acceptability.

RESULTS:

101 participants attended a session, and 77 follow-up surveys were completed. Over 90% participants and 100% panelists endorsed usefulness of the case discussions and usability of the technology. The majority felt it provided new information they will use.

CONCLUSIONS:

A multidisciplinary genetics board was successfully developed to address complexity in prostate cancer genetics. The virtual platform may enhance dissemination of expertise where there are regional gaps.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United kingdom